CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has appointed Gwen A. Fyfe, M.D., and Norman C. Selby as independent members of its board of directors. Dr. Fyfe is an oncology biotechnology veteran with more than 20 years of drug development experience, most recently at Genentech, Inc. Mr. Selby is a seasoned business leader with more than 30 years of experience leading and advising companies in the healthcare industry.
